glp 1 tapasz Fogyás GLP-1 fogyókúrás Custom Logo Label Transdermal Absorbing
Description
Other ASCO-presented research found that people with stage I, II, or III lung, breast, colorectal, or liver cancer who took a GLP-1 drug were less likely to progress to stage IV disease than those who did not take one
doi: 10.1002/psc.1328 71 BianchiECarringtonPEIngallinellaPFinottoMSantopreteAPetrovAet al
ArticlePubMed 106
doi:10.1016/s0140-6736(02)09335-2 12
Differences in the central anorectic effects of glucagon-like peptide-1 and exendin-4 in rats
Eli Lilly praised the ruling, claiming it would eliminate risky, unapproved knockoffs of the drugs
